You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'recombinant'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16.3 KDa. Observed: 16 KDa, reducing conditions
Human
Met1-Val128
N-6His
50 μg, 500 μg, 1 mg, 10 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.07 KDa. Observed: 14-20 KDa, reducing conditions
Human
Met1-Val132
N-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 22.33 KDa. Observed: 18-26 KDa, reducing conditions
Human
Met1-Ala188
N-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 17.5 KDa. Observed: 17 KDa, reducing conditions
Human
Met1-Gln139
N-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 18.7 KDa. Observed: 17 KDa, reducing conditions
Human
Leu292-Met432
N-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15 KDa. Observed: 16 KDa, reducing conditions
Human
Met1-Phe113
N-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 18.6 KDa. Observed: 22 KDa, reducing conditions
Human
Met1-Ile144
N-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 12.5 KDa. Observed: 14 KDa, reducing conditions
Human
Met1-Gly89
N-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 25.24 KDa. Observed: 38 KDa, reducing conditions
Human
Ile27-Pro250
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 33.18 KDa. Observed: 42 KDa, reducing conditions
Human
Gln21-Ser298
C-6His
50 μg, 500 μg, 1 mg, 10 μg